CD300E and pancreatic adenocarcinoma: For disease-free interval (DFI), progression-free interval (PFI), and disease-free survival (DFS), CD300E was a risk factor in KIRP, PAAD, and GBM, and a protective factor in LGG and CHOL (Figure 3A).